Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM. uri icon

authors

  • Khera, Rohan
  • Arshad, Faaizah
  • Blacketer, Clair
  • Chai, Yi
  • Chattopadhyay, Shounak
  • Cook, Michael
  • Dorr, David A
  • Duarte-Salles, Talita
  • DuVall, Scott L
  • Falconer, Thomas
  • French, Tina E
  • Aminorroaya, Arya
  • Hanchrow, Elizabeth E
  • Kaur, Guneet
  • Lau, Wallis C Y
  • Li, Jing
  • Li, Kelly
  • Liu, Yuntian
  • Lu, Yuan
  • Man, Kenneth K C
  • Matheny, Michael E
  • Mathioudakis, Nestoras
  • Dhingra, Lovedeep Singh
  • McLeggon, Jody-Ann
  • McLemore, Michael F
  • Minty, Evan
  • Morales, Daniel R
  • Nagy, Paul
  • Ostropolets, Anna
  • Pistillo, Andrea
  • Phan, Thanh-Phuc
  • Pratt, Nicole
  • Reyes, Carlen
  • Thangaraj, Phyllis M
  • Richter, Lauren
  • Joseph S. Ross, MD, MHS
  • Ruan, Elise
  • Seager, Sarah L
  • Simon, Katherine R
  • Viernes, Benjamin
  • Yang, Jianxiao
  • Yin, Can
  • You, Seng Chan
  • Zhou, Jin J
  • Pedroso Camargos, Aline
  • Ryan, Patrick B
  • Schuemie, Martijn J
  • Krumholz, Harlan M
  • Hripcsak, George
  • Suchard, Marc A
  • Bu, Fan
  • Ding, Xiyu
  • Nishimura, Akihiko
  • Anand, Tara V

publication date

  • September 3, 2024